Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Jul;103(3):1757–1763. doi: 10.1111/j.1476-5381.1991.tb09859.x

Characterization of prejunctional muscarinic autoreceptors in the guinea-pig trachea.

H Kilbinger 1, R Schneider 1, H Siefken 1, D Wolf 1, G D'Agostino 1
PMCID: PMC1907820  PMID: 1933138

Abstract

1. The effects of ten muscarinic antagonists on electrically evoked [3H]-acetylcholine release and muscle contraction were compared in an epithelium-free preparation of the guinea-pig trachea that had been preincubated with [3H]-choline. 2. The M3-selective antagonists UH-AH 37, 4-diphenyl-acetoxy-N-piperidine methobromide and para-fluorohexahydrosiladiphenidol were more potent in reducing the contractile response than in facilitating the evoked [3H]-acetylcholine release. Hexahydrosiladiphenidol did not discriminate between pre- and postjunctional effects. The rank order of the postjunctional potencies of the ten antagonists as well as the postjunctional pA2 values obtained for hexahydrosiladiphenidol (7.95) and AQ-RA (7.08) identified the muscular receptor as an M3 subtype. 3. The M2-selective antagonists methoctramine, AF-DX 116 and AQ-RA 741 were more potent in facilitating the evoked [3H]-acetylcholine release than in inhibiting the contractile response. The increase in release by low concentrations of methoctramine, AF-DX 116 and AQ-RA 741 was paralleled by an enhancement of the stimulation-evoked contractions. 4. Comparison of the pre- and postjunctional potencies of the M1-, M2- and M3-selective antagonists suggests that autoinhibition of acetylcholine release is mediated via an 'M2-like' receptor which differs from the cardiac type M2 receptor in its relatively high affinity for hexahydrosiladiphenidol.

Full text

PDF
1757

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barker L. A., Dowdall M. J., Whittaker V. P. Choline metabolism in the cerebral cortex of guinea pigs. Stable-bound acetylcholine. Biochem J. 1972 Dec;130(4):1063–1075. doi: 10.1042/bj1301063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barlow R. B., Berry K. J., Glenton P. A., Nilolaou N. M., Soh K. S. A comparison of affinity constants for muscarine-sensitive acetylcholine receptors in guinea-pig atrial pacemaker cells at 29 degrees C and in ileum at 29 degrees C and 37 degrees C. Br J Pharmacol. 1976 Dec;58(4):613–620. doi: 10.1111/j.1476-5381.1976.tb08631.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bognar I. T., Wesner M. T., Fuder H. Muscarine receptor types mediating autoinhibition of acetylcholine release and sphincter contraction in the guinea-pig iris. Naunyn Schmiedebergs Arch Pharmacol. 1990 Jan-Feb;341(1-2):22–29. doi: 10.1007/BF00195053. [DOI] [PubMed] [Google Scholar]
  5. Bonner T. I. The molecular basis of muscarinic receptor diversity. Trends Neurosci. 1989 Apr;12(4):148–151. doi: 10.1016/0166-2236(89)90054-4. [DOI] [PubMed] [Google Scholar]
  6. Buckley N. J., Bonner T. I., Buckley C. M., Brann M. R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol. 1989 Apr;35(4):469–476. [PubMed] [Google Scholar]
  7. D'Agostino G., Chiari M. C., Grana E., Subissi A., Kilbinger H. Muscarinic inhibition of acetylcholine release from a novel in vitro preparation of the guinea-pig trachea. Naunyn Schmiedebergs Arch Pharmacol. 1990 Aug;342(2):141–145. doi: 10.1007/BF00166956. [DOI] [PubMed] [Google Scholar]
  8. Eberlein W. G., Engel W., Mihm G., Rudolf K., Wetzel B., Entzeroth M., Mayer N., Doods H. N. Structure-activity relationships and pharmacological profile of selective tricyclic antimuscarinics. Trends Pharmacol Sci. 1989 Dec;Suppl:50–54. [PubMed] [Google Scholar]
  9. Eglen R. M., Michel A. D., Montgomery W. W., Kunysz E. A., Machado C. A., Whiting R. L. The interaction of parafluorohexahydrosiladiphenidol at muscarinic receptors in vitro. Br J Pharmacol. 1990 Apr;99(4):637–642. doi: 10.1111/j.1476-5381.1990.tb12983.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Eglen R. M., Whiting R. L. Comparison of the muscarinic receptors of the guinea-pig oesophageal muscularis mucosae and trachea in vitro. J Auton Pharmacol. 1988 Sep;8(3):181–189. doi: 10.1111/j.1474-8673.1988.tb00181.x. [DOI] [PubMed] [Google Scholar]
  11. Fryer A. D., Maclagan J. Ipratropium bromide potentiates bronchoconstriction induced by vagal nerve stimulation in the guinea-pig. Eur J Pharmacol. 1987 Jul 9;139(2):187–191. doi: 10.1016/0014-2999(87)90251-2. [DOI] [PubMed] [Google Scholar]
  12. Fryer A. D., Maclagan J. Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol. 1984 Dec;83(4):973–978. doi: 10.1111/j.1476-5381.1984.tb16539.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fuder H., Kilbinger H., Müller H. Organ selectivity of hexahydrosiladifenidol in blocking pre- and postjunctional muscarinic receptors studied in guinea-pig ileum and rat heart. Eur J Pharmacol. 1985 Jul 11;113(1):125–127. doi: 10.1016/0014-2999(85)90352-8. [DOI] [PubMed] [Google Scholar]
  14. Fuder H., Meiser C., Wormstall H., Muscholl E. The effects of several muscarinic antagonists on pre- and postsynaptic receptors in the isolated rabbit heart. Naunyn Schmiedebergs Arch Pharmacol. 1981 Feb;316(1):31–37. doi: 10.1007/BF00507223. [DOI] [PubMed] [Google Scholar]
  15. Hulme E. C., Birdsall N. J., Buckley N. J. Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol. 1990;30:633–673. doi: 10.1146/annurev.pa.30.040190.003221. [DOI] [PubMed] [Google Scholar]
  16. Kilbinger H., Nafziger M. Two types of neuronal muscarine receptors modulating acetylcholine release from guinea-pig myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jan;328(3):304–309. doi: 10.1007/BF00515558. [DOI] [PubMed] [Google Scholar]
  17. Lambrecht G., Feifel R., Forth B., Strohmann C., Tacke R., Mutschler E. p-fluoro-hexahydro-sila-difenidol: the first M2 beta-selective muscarinic antagonist. Eur J Pharmacol. 1988 Jul 26;152(1-2):193–194. doi: 10.1016/0014-2999(88)90856-4. [DOI] [PubMed] [Google Scholar]
  18. Lindmar R., Löffelholz K., Weide W. Interstitial washout and hydrolysis of acetylcholine in the perfused heart. Naunyn Schmiedebergs Arch Pharmacol. 1982 Mar;318(4):295–300. doi: 10.1007/BF00501168. [DOI] [PubMed] [Google Scholar]
  19. Maclagan J., Barnes P. J. Muscarinic pharmacology of the airways. Trends Pharmacol Sci. 1989 Dec;Suppl:88–92. [PubMed] [Google Scholar]
  20. Melchiorre C. Polymethylene tetramines: a new generation of selective muscarinic antagonists. Trends Pharmacol Sci. 1988 Jun;9(6):216–220. doi: 10.1016/0165-6147(88)90089-2. [DOI] [PubMed] [Google Scholar]
  21. Micheletti R., Montagna E., Giachetti A. AF-DX 116, a cardioselective muscarinic antagonist. J Pharmacol Exp Ther. 1987 May;241(2):628–634. [PubMed] [Google Scholar]
  22. Minette P. A., Barnes P. J. Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways. J Appl Physiol (1985) 1988 Jun;64(6):2532–2537. doi: 10.1152/jappl.1988.64.6.2532. [DOI] [PubMed] [Google Scholar]
  23. Starke K., Göthert M., Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev. 1989 Jul;69(3):864–989. doi: 10.1152/physrev.1989.69.3.864. [DOI] [PubMed] [Google Scholar]
  24. Wessler I., Hellwig D., Racké K. Epithelium-derived inhibition of [3H]acetylcholine release from the isolated guinea-pig trachea. Naunyn Schmiedebergs Arch Pharmacol. 1990 Oct;342(4):387–393. doi: 10.1007/BF00169454. [DOI] [PubMed] [Google Scholar]
  25. van Charldorp K. J., van Zwieten P. A. Comparison of the muscarinic receptors in the coronary artery, cerebral artery and atrium of the pig. Naunyn Schmiedebergs Arch Pharmacol. 1989 Apr;339(4):403–408. doi: 10.1007/BF00736054. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES